Bavarian Nordic A/S (OTCMKTS:BVNRY) Share Price Crosses Below 200 Day Moving Average of $7.95

Bavarian Nordic A/S (OTCMKTS:BVNRY)’s share price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $7.95 and traded as low as $7.91. Bavarian Nordic A/S shares last traded at $7.93, with a volume of 2,795 shares trading hands.

Bavarian Nordic A/S Trading Down 2.9 %

The company has a market cap of $1.80 billion, a price-to-earnings ratio of 8.09 and a beta of 1.65. The stock’s 50-day moving average is $7.88 and its 200-day moving average is $7.95.

Bavarian Nordic A/S (OTCMKTS:BVNRY) last released its quarterly earnings data on Wednesday, May 8th. The company reported ($0.07) earnings per share for the quarter. The business had revenue of $121.08 million during the quarter. Bavarian Nordic A/S had a net margin of 14.74% and a return on equity of 16.11%. As a group, analysts predict that Bavarian Nordic A/S will post 0.52 EPS for the current year.

Bavarian Nordic A/S Company Profile

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.